I think there is something to be said about going to early and delivering false hope to suffers, being a small phase 1 trial. I don’t think the responsibility parties we are partnered with would like to be seen to be doing that. You saw the subdued response from Prof. Mather to the results and the patient testimonials.
Associate Professor Susan Mathers commented:
“This study has shown oral Monepantel to be safe and well tolerated by people with MND. Given the promising
findings on preliminary efficacy markers, I look forward to progressing a phase 2 study as soon as possible”
I read quite a bit into this line about looking fwd to starting phase 2 asap.
- Forums
- ASX - By Stock
- PAA
- The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-778
-
- There are more pages in this discussion • 647 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
(20min delay)
|
|||||
Last
17.8¢ |
Change
0.003(1.43%) |
Mkt cap ! $86.33M |
Open | High | Low | Value | Volume |
18.0¢ | 18.0¢ | 17.5¢ | $32.88K | 184.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 488397 | 17.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
18.0¢ | 143879 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 488397 | 0.175 |
12 | 544707 | 0.170 |
6 | 163124 | 0.165 |
9 | 476304 | 0.160 |
6 | 336734 | 0.155 |
Price($) | Vol. | No. |
---|---|---|
0.180 | 143879 | 6 |
0.185 | 433617 | 6 |
0.190 | 720215 | 6 |
0.195 | 750282 | 11 |
0.200 | 307726 | 11 |
Last trade - 10.41am 06/09/2024 (20 minute delay) ? |
Featured News
PAA (ASX) Chart |